Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.
Sakamoto K, Kawamura M, Kohro T, Omura M, Watanabe T, Ashidate K, Horiuchi T, Hara H, Sekine N, Chin R, Tsujino M, Hiyoshi T, Tagami M, Tanaka A, Mori Y, Inazawa T, Hirano T, Yamazaki T, Shiba T; RESEARCH Study Group. Sakamoto K, et al. Among authors: omura m. PLoS One. 2015 Sep 23;10(9):e0138332. doi: 10.1371/journal.pone.0138332. eCollection 2015. PLoS One. 2015. PMID: 26398887 Free PMC article. Clinical Trial.
Comparative study of the effects of ipragliflozin and sitagliptin on multiple metabolic variables in Japanese patients with type 2 diabetes: A multicentre, randomized, prospective, open-label, active-controlled study.
Tsurutani Y, Nakai K, Inoue K, Azuma K, Mukai S, Maruyama S, Iizuka T, Matsuzawa Y, Saito J, Omura M, Nishikawa T. Tsurutani Y, et al. Among authors: omura m. Diabetes Obes Metab. 2018 Nov;20(11):2675-2679. doi: 10.1111/dom.13421. Epub 2018 Jul 4. Diabetes Obes Metab. 2018. PMID: 29893003 Clinical Trial.
Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl)-3, 4-dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in patients with non-insulin dependent diabetes mellitus.
Nishikawa T, Omura M, Iizuka T, Saito I, Yoshida S. Nishikawa T, et al. Among authors: omura m. Arzneimittelforschung. 1996 Sep;46(9):875-8. Arzneimittelforschung. 1996. PMID: 8876935 Clinical Trial.
387 results